৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Indications
Constipation
Hemorrhoids (piles)
Bowel regulation for bedridden patients
Composition (per 5.38 g spoonful)
Psyllium fiber (Ispaghula husk) – 3.5 g
Standardized Senna extract (Cassia angustifolia) – equivalent to Sennoside B 7.5 mg
Pharmacology
Psyllium fiber acts as a bulk‑forming laxative. It absorbs water, increases stool volume, and promotes smooth bowel movement.
Senna extract is a stimulant laxative containing hydroxyanthracene glycosides (Sennosides A & B) that stimulate intestinal motility.
The combination accelerates intestinal passage, increases water absorption, and ensures effective relief from constipation.
Dosage & Administration
Adults & children over 12 years: 1–2 spoonfuls at night with at least 150 ml water (or as directed by physician).
Can be taken with fruit juice, milk, or warm drink.
Avoid taking within ½–1 hour of other medications.
Side Effects
Mild abdominal cramps or bloating may occur initially.
Excessive use may cause diarrhea or electrolyte imbalance.
Storage
Store below 30 °C in a dry place, protected from light.
Keep out of reach of children.
Aflibercept: A recombinant fusion protein, classified as a VEGF inhibitor (vascular endothelial growth factor inhibitor).
Marketed under brand names such as Eylea and Zaltrap.
Used in ophthalmology for retinal diseases:
Age‑related macular degeneration (AMD)
Diabetic macular edema (DME)
Retinal vein occlusion (RVO)
Used in oncology (as Zaltrap) in combination with chemotherapy for metastatic colorectal cancer.
Acts as a VEGF trap: binds VEGF‑A, VEGF‑B, and placental growth factor (PlGF).
Prevents abnormal blood vessel growth and leakage in the eye.
In cancer, reduces angiogenesis (formation of new blood vessels that feed tumors).
Improves vision in patients with retinal diseases.
Reduces macular swelling and leakage.
Slows progression of neovascular AMD.
Enhances effectiveness of chemotherapy in colorectal cancer.






Vision improvement
Enhances visual acuity in patients with age‑related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).
Macular swelling reduction
Decreases fluid leakage and swelling in the retina, improving central vision.
Disease progression control
Slows progression of neovascular AMD and other retinal vascular diseases.
Angiogenesis inhibition
Blocks VEGF‑A, VEGF‑B, and PlGF, preventing abnormal blood vessel growth in the eye and tumors.
Cancer therapy support
In oncology (Zaltrap), enhances chemotherapy effectiveness in metastatic colorectal cancer by reducing tumor blood supply.
Combination therapy potential
Can be used alongside other treatments for synergistic effects in both eye diseases and cancer.




